PNC Financial Services Group’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$311K Buy
8,119
+25
+0.3% +$655 ﹤0.01% 2136
2026
Q1
$172K Sell
8,094
-593
-7% -$11.9K ﹤0.01% 2438
2025
Q4
$142K Sell
8,687
-292
-3% -$4.41K ﹤0.01% 2549
2025
Q3
$105K Buy
8,979
+28
+0.3% +$365 ﹤0.01% 2771
2025
Q2
$104K Buy
8,951
+3,801
+74% +$34.6K ﹤0.01% 2688
2025
Q1
$45K Buy
5,150
+3,119
+154% +$39.3K ﹤0.01% 3161
2024
Q4
$29.2K Sell
2,031
-193
-9% -$3.05K ﹤0.01% 3366
2024
Q3
$50.2K Buy
2,224
+537
+32% +$11.1K ﹤0.01% 3088
2024
Q2
$32.8K Buy
1,687
+144
+9% +$3.77K ﹤0.01% 3245
2024
Q1
$57.9K Buy
1,543
+167
+12% +$7.34K ﹤0.01% 2923
2023
Q4
$77K Buy
1,376
+72
+6% +$3.13K ﹤0.01% 2750
2023
Q3
$53.8K Buy
1,304
+5
+0.4% +$260 ﹤0.01% 2927
2023
Q2
$72.5K Buy
1,299
+197
+18% +$10.7K ﹤0.01% 2830
2023
Q1
$61.5K Sell
1,102
-322
-23% -$15K ﹤0.01% 2867
2022
Q4
$51.9K Sell
1,424
-768
-35% -$25.1K ﹤0.01% 2963
2022
Q3
$62K Buy
2,192
+354
+19% +$13.5K ﹤0.01% 2836
2022
Q2
$83K Sell
1,838
-208
-10% -$10.8K ﹤0.01% 2690
2022
Q1
$155K Buy
2,046
+1,761
+618% +$154K ﹤0.01% 2428
2021
Q4
$41K Buy
285
+118
+71% +$18.1K ﹤0.01% 3224
2021
Q3
$23K Sell
167
-65
-28% -$11.2K ﹤0.01% 3447
2021
Q2
$46K Buy
232
+9
+4% +$1.63K ﹤0.01% 3117
2021
Q1
$41K Buy
223
+39
+21% +$6.74K ﹤0.01% 3098
2020
Q4
$25K Buy
184
+123
+202% +$17.8K ﹤0.01% 3248
2020
Q3
$7K Buy
61
+12
+24% +$1.26K ﹤0.01% 3612
2020
Q2
$4K Buy
+49
New +$3.82K ﹤0.01% 3691

Other funds holding TXG

PNC Financial Services Group's TXG Position: Q2 2026 in Review

PNC Financial Services Group increased its 10x Genomics (TXG) stake by 0.31% in Q2 2026, buying an estimated $655 and bringing the position to 8,119 shares worth $311K. The position accounts for ﹤0.01% of the portfolio, ranked #2136.

PNC Financial Services Group first reported a position in TXG in Q2 2020 and has held it in 25 quarters since. 194 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • PNC Financial Services Group held 8,119 shares of 10x Genomics worth $311K as of Q2 2026.
  • PNC Financial Services Group bought 25 10x Genomics shares in Q2 2026, an estimated $655.
  • 10x Genomics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #2136 holding.
  • PNC Financial Services Group first reported a position in 10x Genomics in Q2 2020 and has held it in 25 quarters since.
  • 194 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.